Sponsor / Institution

Teofarma Iberica SA

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All Programs Therapeutics Devices

Open filtered programs

Programs

linked to organization

Strong Evidence

0 status confirmed

Details Checked

0 open data checks

Company / Institution Links

0 / 1

industry vs non-industry records

Competitive Density

Pipeline Velocity

Completion Signal

100

Programs by Stage

Phase 41

Trial / Program Status

Completed1

Modality Mix

Small Molecule1

Indication Coverage

Cerumen Impaction1

Hearing Loss1

Program Types

Therapeutic1

Population Tags

adult1

cerumen1

Strong-Evidence Records

0 records

No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks

Hospital Clinic Barcelona Cerumenolytic Ear Drops Study

Details checked

Small MoleculePhase 4Completed

Academic randomized Phase 4 comparison of ceruminolytic ear-drop products before ear irrigation in adults with complete cerumen occlusion. Otocerum contains chlorobutanol/phenol/turpentine essence/ethyl alcohol, Taponoto contains potassium carbonate/ethyl alcohol/glycerol/thymol, and saline served as control; the compared drops are study arms rather than separate hearing-loss pipeline programs.

Data checks: merged-generated-intervention-arms, institution-led-study